Method for producing a thiocarbonyl flavone analogue and its derivatives and their use for inhibiting the metabolic activity of melanoma cells cultured in vitro carrying mutations in the FAT4, OR6C70, MUC16, DNAH7, TTN, BRAFi and SCN9A genes
PL451858A1Pending Publication Date: 2026-11-16UNIV RZESZOWSKI +1
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- PL2025451858
- Authority / Receiving Office
- PL · PL
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2025-04-24
- Publication Date
- 2026-11-16
Abstract
The subject of the application is a thiocarbonyl analogue of a flavone of the formula: TF-(OR)k(OR)'m(OR")n, wherein TF is a 2-phenyl-chromen-4-thione structure; OR, OR' and OR" denote a free hydroxyl group (when R, R' and R" is a hydrogen atom) or protected (when R, R' and R" is an acyl or benzyl group); k, m and n are integers and their sum is less than or equal to 10. The subject of the application is also a method for producing a thiocarbonyl analogue of a flavone and its derivatives and their use to inhibit the metabolic activity of melanoma cells cultured in vitro having mutations in the FAT4, OR6C70, MUC16, DNAH7, TTN, BRAF, SCN9A genes. The thiocarbonyl analogue of flavone and its derivatives may find potential application in the pharmaceutical industry and oncology as a biologically active compound with anticancer activity.
Need to check novelty before this filing date? Find Prior Art
